On February 26, Arkema released its 2025 financial results. Amid a challenging macroeconomic environment, the Group delivered robust cash flow performance through rigorous operational management.

Against a backdrop of weak demand in the US and Europe and relatively dynamic markets in Asia, the Group posted an EBITDA of €1.251 billion, representing an EBITDA margin of 13.8%, within the guidance range. Compared with 2024, key projects contributed
approximately €60 million in incremental EBITDA. Despite the cyclical volatility in the acrylics segment and the scaling-back of legacy refrigerants, the Specialty Materials business demonstrated strong resilience.

Arkema generated a record recurring cash flow of €464 million in 2025, far exceeding the €300 million guidance, further strengthening the robustness of its balance sheet. High-attractiveness key markets maintained strong growth momentum, with sales up 16% year-on-year, including batteries, sporting goods, 3D printing, healthcare, and fluorinated specialty materials. Three expansion projects, located in the US and Asia respectively, were successfully commissioned, completed on schedule and within budget.

Starting from 2026, Arkema will adjust its business segment structure to better reflect the evolving portfolio and enhance the profitability transparency of the Specialty Materials business (2025 margin: 15.7%). On a constant currency basis, the year-on-year decline in EBITDA was contained within 5%. Against a backdrop of persistently weak overall macroeconomic demand, Arkema expects a modest increase in 2026 EBITDA on a constant currency basis. The Group will continue to rigorously control operating costs to offset the impact of fixed-cost inflation, while maintaining capital expenditure at around €600 million.